Victoria Ball
Adult Health · Saginaw, MINPI 1093996837
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 204 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 20 manufacturers, the largest accounting for just 21.3% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,406, 5.5 times the $258 reported in 2021. Among adult health clinicians in MI with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 204 payments — averaging $20.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alkermes, Inc.$887
- Lundbeck LLC$786
- Teva Pharmaceuticals USA, Inc.$453
- Johnson & Johnson$347
- Neurocrine Biosciences, Inc.$277
- AbbVie$238
- plus $1K from 14 others
What the payments were for
- Food & beverage$4,174100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alkermes, Inc. | 32 | $887 |
| Lundbeck LLC | 60 | $786 |
| Teva Pharmaceuticals USA, Inc. | 23 | $453 |
| Johnson & Johnson | 11 | $347 |
| Neurocrine Biosciences, Inc. | 10 | $277 |
| AbbVie(2 entities) | 13 | $238 |
| Axsome Therapeutics, Inc. | 12 | $230 |
| Otsuka America Pharmaceutical, Inc. | 6 | $197 |
| Vanda Pharmaceuticals Inc. | 6 | $133 |
| Indivior Inc. | 6 | $125 |
| USWM, LLC | 6 | $117 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 5 | $91 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $68 |
| E.r. Squibb & Sons, L.L.C. | 3 | $62 |
| Biogen | 2 | $43 |
| Ferring Pharmaceuticals Inc. | 1 | $38 |
| Sage Therapeutics, LLC | 1 | $28 |
| Ironshore Pharmaceuticals Inc. | 1 | $20 |
| Braeburn Inc. | 1 | $18 |
| Lilly USA, LLC | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,174 in reported general payments places this provider in the 90th percentile of 527 adult health providers in Michigan.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RexultiBrexpiprazole | 60 | $92,295 |
| VraylarCariprazine Hcl | 22 | $34,435 |
| TrintellixVortioxetine Hydrobromide | 62 | $33,415 |
| Abilify MaintenaAripiprazole | 12 | $29,837 |
| VivitrolNaltrexone Microspheres | 13 | $20,878 |
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 152 | $9,467 |
| ZubsolvBuprenorphine Hcl/Naloxone Hcl | 60 | $4,631 |
| Incruse ElliptaUmeclidinium Bromide | 11 | $3,445 |
| Trazodone Hcl | 186 | $2,348 |
| Bupropion XlBupropion Hcl | 174 | $2,227 |
| Vilazodone Hcl | 29 | $1,967 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 44 | $1,895 |
| Buspirone Hcl | 161 | $1,777 |
| Oxcarbazepine | 50 | $1,483 |
| Divalproex Sodium ErDivalproex Sodium | 26 | $1,358 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Otsuka America Pharmaceutical, Inc.Rexulti, Abilify Maintena | $197 | $122,13272 claims |
| AbbVieVraylar | $238 | $34,43522 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix | $68 | $33,41562 claims |
| Alkermes, Inc.Vivitrol | $887 | $20,87813 claims |
| Lilly USA, LLCOlanzapine | $15 | $37522 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 527 adult health providers in Michigan.
Other adult health in Saginaw
- Janice BakerSaginaw$4K
- Shannon OchoaSaginaw$4K
- Jacqueline BrewerSterling Heights$138K
- Linda Morris McCoyGrand Rapids$59K
- Sarita RaoCanton$51K
- Susanne QuallichAnn Arbor$42K
- Nancy BermanSouthfield$39K
- Michelle MillerQuincy$24K
- Deniene KingAnn Arbor$14K
- Adama JohnsonEastpointe$14K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.